BR0107421A - Processos de preparação de uma solução purificada de polipeptìdeo solúvel em solvente aquoso e de modulação do sistema imunológico de um mamìfero, polipeptìdeo recombinante, utilização de um polipeptìdeo recombinante, composição terapêutica e vacina - Google Patents

Processos de preparação de uma solução purificada de polipeptìdeo solúvel em solvente aquoso e de modulação do sistema imunológico de um mamìfero, polipeptìdeo recombinante, utilização de um polipeptìdeo recombinante, composição terapêutica e vacina

Info

Publication number
BR0107421A
BR0107421A BR0107421-0A BR0107421A BR0107421A BR 0107421 A BR0107421 A BR 0107421A BR 0107421 A BR0107421 A BR 0107421A BR 0107421 A BR0107421 A BR 0107421A
Authority
BR
Brazil
Prior art keywords
polypeptide
recombinant polypeptide
aqueous solvent
soluble
processes
Prior art date
Application number
BR0107421-0A
Other languages
English (en)
Inventor
Thierry Baussant
Pascale Jeannin
Yves Delneste
Francois Lawny
Jean-Yves Bonnefoy
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of BR0107421A publication Critical patent/BR0107421A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Water Supply & Treatment (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

"PROCESSOS DE PREPARAçãO DE UMA SOLUçãO PURIFICADA DE POLIPEPTìDEO SOLúVEL EM SOLVENTE AQUOSO E DE MODULAçãO DO SISTEMA IMUNOLóGICO DE UM MAMìFERO, POLIPEPTìDEO RECOMBINANTE, UTILIZAçãO DE UM POLIPEPTìDEO RECOMBINANTE, COMPOSIçãO TERAPêUTICA E VACINA". A presente invenção refere-se a um novo processo de preparação de um polipeptídeo solúvel em solvente aquoso em ausência de detergente, assim como aos polipeptídeos susceptíveis de serem obtidos pelo processo de acordo com a invenção. A invenção refere-se também à utilização de tais polipeptídeos, particularmente para a preparação de medicamentos ou vacinas, destinados a combater particularmente as infecções bacterianas, virais ou os cânceres.
BR0107421-0A 2000-01-04 2001-01-04 Processos de preparação de uma solução purificada de polipeptìdeo solúvel em solvente aquoso e de modulação do sistema imunológico de um mamìfero, polipeptìdeo recombinante, utilização de um polipeptìdeo recombinante, composição terapêutica e vacina BR0107421A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0000070A FR2803302B1 (fr) 2000-01-04 2000-01-04 Procede de preparation d'un polypeptide soluble en solvant aqueux en absence de detergent
PCT/FR2001/000023 WO2001049705A2 (fr) 2000-01-04 2001-01-04 Procede de preparation d'un polypeptide soluble en solvant aqueux en absence de detergent

Publications (1)

Publication Number Publication Date
BR0107421A true BR0107421A (pt) 2002-10-22

Family

ID=8845624

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0107421-0A BR0107421A (pt) 2000-01-04 2001-01-04 Processos de preparação de uma solução purificada de polipeptìdeo solúvel em solvente aquoso e de modulação do sistema imunológico de um mamìfero, polipeptìdeo recombinante, utilização de um polipeptìdeo recombinante, composição terapêutica e vacina

Country Status (13)

Country Link
US (1) US7125696B2 (pt)
EP (1) EP1244690B1 (pt)
JP (1) JP2003519238A (pt)
CN (1) CN1258537C (pt)
AT (1) ATE364622T1 (pt)
AU (1) AU783851B2 (pt)
BR (1) BR0107421A (pt)
CA (1) CA2397714A1 (pt)
DE (1) DE60128891D1 (pt)
FR (1) FR2803302B1 (pt)
MX (1) MXPA02006650A (pt)
WO (1) WO2001049705A2 (pt)
ZA (1) ZA200204930B (pt)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3809796A1 (de) * 1988-03-23 1989-10-05 Wolfgang Prof Dr Med Bredt Verfahren zum reinigen eines 168 kd-proteins von mycoplasma pneumoniae
DE4139840B4 (de) * 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
US5534205A (en) * 1994-08-05 1996-07-09 The Dow Chemical Company Method for preparing polybenzoxazole or polybenzothiazole fibers
FR2726472B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin
KR0158435B1 (ko) 1996-01-30 1998-11-16 허영섭 헬리코박터 파이로리의 외막단백질 유전자 및 그를 발현하는 재조합 미생물
ID20411A (id) 1997-01-23 1998-12-10 Daicel Chem Bagian permukaan perekaman dan proses produksi daripadanya
ATE286080T1 (de) 1998-06-15 2005-01-15 Union Carbide Chem Plastic In alkali lösliche verdickungsmittel für latex
FR2785542B1 (fr) * 1998-11-06 2001-02-09 Pf Medicament UTILISATION D'UNE PROTEINE OmpA D'ENTEROBACTERIE, POUR LE CIBLAGE SPECIFIQUE D'UNE SUBSTANCE BIOLOGIQUEMENT ACTIVE QUI LUI EST ASSOCIEE VERS LES CELLULES PRESENTATRICES D'ANTIGENES TELLES QUE LES CELLULES DENDRITIQUES HUMAINES
FR2789588B1 (fr) * 1999-02-17 2001-05-04 Pf Medicament Utilisation d'une proteine ompa d'enterobacterie associee a un antigene dans une composition pharmaceutique destinee a generer ou accroitre une reponse cytotoxique antivirale, antiparasitaire ou antitumorale
FR2789902A1 (fr) 1999-02-24 2000-08-25 Pf Medicament PROTEINE OmpA DE KLEBSIELLA PNEUMONIAE ASSOCIEE A LA CHAINE BETA DE L'HORMONE hCG OU A UN COMPOSE IMPLIQUE DANS LA PROLIFERATION DE CELLULES TUMORALES OU DANS LA FERTILITE, UTILE DANS UNE COMPOSITION PHARMACEUTIQUE
EP1114844A4 (en) 1999-05-28 2005-03-16 Jsr Corp THERMOPLASTIC ELASTOMER EMULSION AND METHOD OF PRODUCING THE SAME

Also Published As

Publication number Publication date
EP1244690B1 (fr) 2007-06-13
CA2397714A1 (fr) 2001-07-12
AU3183701A (en) 2001-07-16
ZA200204930B (en) 2003-02-06
ATE364622T1 (de) 2007-07-15
WO2001049705A3 (fr) 2002-02-14
US20030044915A1 (en) 2003-03-06
MXPA02006650A (es) 2002-09-30
WO2001049705A2 (fr) 2001-07-12
FR2803302B1 (fr) 2004-12-10
DE60128891D1 (de) 2007-07-26
JP2003519238A (ja) 2003-06-17
FR2803302A1 (fr) 2001-07-06
EP1244690A2 (fr) 2002-10-02
CN1258537C (zh) 2006-06-07
AU783851B2 (en) 2005-12-15
US7125696B2 (en) 2006-10-24
CN1396927A (zh) 2003-02-12

Similar Documents

Publication Publication Date Title
PE20231439A1 (es) Proteinas f de hmpv estabilizadas por prefusion
BR9907691A (pt) Derivados de antìgeno associado a tumor da famìlia mage, e sequências de ácido nucléico codificando os mesmos, usados para a preparação de proteìnas de fusão e de composições para vacinação
BR9510590A (pt) Processo para produzir vacinas multivalentes de hemoglutinina de gripe.
DE69829668D1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
AR058567A1 (es) Formulaciones de proteinas estables
BR9809456A (pt) Molécula isolada de polinucleotìdeo, composição de célula ou isenta de célula, processo para produzir umaa partìcula de piv infeccioso de uma ou mais moléculas isoladas de polinucleotìdeo, partìcula isolada de piv infecioso, e, composição imunogênica
KR960031602A (ko) 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조 방법
PE20121541A1 (es) Antigenos de virus de sincicio respiratorio recombinantes
PE20011217A1 (es) Composicion farmaceutica para modulacion inmunologica y preparacion de vacunas
BR0113921A (pt) ácidos nucléicos e polipeptìdeos receptores
FI932678A7 (fi) Alfaviruksiin perustuvia DNA-ilmentämissysteemejä
BR0015137A (pt) Peptìdeos antigênicos de neisseria
PT677114E (pt) Virus da variola suina recombinante
AR062300A2 (es) Polipeptido que comprende una porcion inmunogenica de una proteina de prostata o su variante, molecula de adn, vector de expresion, celula huesped composicion farmaceutica, vacuna uso de dichas composiciones y vacunas para preparar medicamentos y proteina de fusion
WO2021000968A3 (zh) 一种用于预防SARS-CoV-2感染的腺病毒载体疫苗
ES2029171A6 (es) Un procedimiento para preparar un polipeptido virico de hepatitis no a y no b post-transfusional (pt-nanbh)
BR9711457A (pt) Compostos e processo para o tratamento e diagnóstico de infecções micobacterianas.
BR0312474A (pt) Partìcula viral adjuvante
BR0012919A (pt) Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv
BRPI0407840B8 (pt) vírus do sarampo recombinante, composição farmacêutica, uso de uma composição farmacêutica, célula bacteriana, método para produzir um vírus recombinante e uso
ES2127294T3 (es) Vacunas del virus de la inmunodeficiencia anti-felino (fiv).
ES2078971T3 (es) Produccion de virus y purificacion de proteinas con envoltura virica para uso en vacunas.
AR035077A1 (es) Polipeptidos de neublastina variante, proteinas de fusion, acidos nucleicos, vectores, celulas hospedadoras, metodos para producir dichos polipeptidos, dimeros, conjugados, composiciones farmaceuticas y uso de dichos polipeptidos en la preparacion de medicamentos
BR9803960A (pt) Gene de desidrogenase de d-sorbitol.
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A , 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2112 DE 28/06/2011.